Background: Whether Crohn's disease [CD] is correlated with brain structural changes is unclear. This study examined changes in grey matter [GM] structures in CD patients and their correlation with psychological distress. Methods: A total of 45 CD patients and 33 healthy controls were scanned using magnetic resonance imaging [MRI]. Voxel-based morphometry and a cortical thickness analysis were used to determine brain GM volume and cortical thickness. Results: The GM volumes in the CD patients were significantly higher in the putamen, pallidum, thalamus, hippocampal cortex, amygdala, precuneus, posterior parietal cortex, periaqueductal grey, and cerebellum, but were lower in many other cortical regions. The cortical thicknesses of the insula, cingulate cortex, parahippocampal cortex, and other cortical regions were significantly reduced in CD patients. After controlling for psychological distress [anxiety and depression], the differences among several regions involved in emotional processing were not significant. The GM volumes of the right anterior cingulate cortex, dorsomedial prefrontal cortex, and left insula and the cortical thickness of the left insula and orbitofrontal cortex were negatively correlated with disease duration. Conclusions: We suggest that the significant changes in GM structures in multiple brain regions of CD patients can be partially explained by the higher levels of anxiety and depression in these patients. Specific profiles of altered GM structures in CD patients were correlated with disease duration.
Introduction
Crohn's disease [CD] , a type of inflammatory bowel disease [IBD] , is an intestinal inflammatory disease and a relapsing systemic inflammatory disease. Its main manifestations include abdominal pain, diarrhoea, weight loss, fatigue, fever, and symptoms that affect areas outside the gastrointestinal tract. 1 With an annually increasing incidence, CD has become prevalent in Asia, particularly in China. 2 CD occurs primarily in young adults, and profoundly affects their healthrelated quality of life [QOL] 3, 4, 5 and increases work disability. 6, 7 The aetiology of CD remains unclear. The dysregulation of the brain-gut axis may play an important role in the pathogenesis of CD. 8, 9, 10 The central nervous system [CNS] is likely involved in the abnormal processing of the intestinal inflammatory response in IBD. 11, 12, 13 Intestinal inflammatory signals are presumably transmitted to the brain through the brain-gut axis to induce a structural reorganisation of the neuromatrix in the brain, whereas the brain also regulates the gastrointestinal tract through this pathway. Psychological distress [i.e. depression and anxiety] may influence this process through changes in hypothalamic-pituitary-adrenal [HPA] axis function and alterations in inflammatory processes in CD. 14, 15 Studies have shown that 31.3-40.2% of patients in the remission stage still have depression and/or anxiety, which severely influences QOL 16, 17 and may have an impact on disease activity. 15, 18 Brain magnetic resonance imaging [MRI] technology enables a better understanding of the processing of various input signals in specific regions of the brain. Recently, MRI has been used for studying changes in brain grey matter [GM] structures in inflammatory digestive diseases, such as CD, 11, 12 ulcerative colitis, 19 and chronic pancreatitis. 20, 21 Currently, only two studies have examined the brain GM structures in patients with CD, and the conclusions are not consistent. In a study involving 18 CD patients and 18 healthy controls [HCs], Agostini et al. showed that the CD patients exhibited decreased GM volumes in a portion of the frontal cortex and anterior midcingulate cortex [aMCC] ; these authors also showed that disease duration was negatively correlated with GM volume in several brain regions, including the neocortical and limbic areas. 11 Another study by this research group identified no difference in GM concentration between CD patients and HCs. 12 Therefore, further investigations are necessary to determine whether changes exist in specific GM structures in CD patients and whether these changes are correlated with gastrointestinal and psychological symptoms.
GM volume and cortical thickness are two measurements that reflect complementary aspects of neuroanatomy and may have different sensitivities to different pathophysiological processes. Analysis of GM volume using voxel-based morphometry [VBM] offers a mixed measure that reflects different structural properties including the local cortical thickness, cortical folding, and cortical surface area, whereas analysis of cortical thickness specifically targets the existence of cortical atrophy. Thus, the combination of GM volume and cortical thickness measurements would provide more comprehensive information about the underlying pathophysiological changes, and the results would be more credible. 22, 23, 24, 25 In the present study, we therefore expanded sample sizes and employed both VBM and cortical thickness analyses to compare the differences in GM structures between CD patients and HCs. We hypothesised that [1] CD patients display altered GM structures including GM volume and cortical thickness; [2] psychological distress, including anxiety and depression, may be correlated with brain GM structural changes in CD patients; and [3] changes in brain GM in CD patients are correlated with disease duration.
Materials and Methods
This research programme was approved by the Ethics Committee of the Yueyang Hospital of Integrated Traditional Chinese and Western Medicine at Shanghai University of Traditional Chinese Medicine. All subjects signed informed consent forms.
Subjects
This study evaluated 45 
Symptoms and psychological assessment
The disease condition and QOL of all of the patients were evaluated using the CDAI 27 and the Inflammatory Bowel Disease Questionnaire [IBDQ], 28 respectively.
Altered Brain Grey Matter Structures In CD
Psychological status, including anxiety and depression, was assessed using the Hospital Anxiety and Depression Scale [HADS] 29 in all of the subjects.
Image acquisition
The MRI data were acquired in an interleaved multi-slice mode using a SIEMENS TRIO 3T clinical scanner [MagnetomVerio, Siemens, Germany] in the Department of Radiology at the Shanghai Mental Health Center. During the MRI examination, all of the patients and HCs were instructed to relax with their eyes closed without falling asleep or thinking of anything in particular. All of the participants were kept in the supine position with their head supported by a custom-built head holder to minimise head motion and a pair of foam pads to minimise noise. A high-resolution T1-weighted sagittal 3-dimensional magnetisationprepared rapid gradient echo sequence was acquired for each participant: slices, TR = 2300 ms; TE = 2.98 ms, field of view = 256 × 256 mm; matrix size = 256 × 256; in-plane resolution = 1 mm × 1 mm; slice thickness = 1.0 mm,]; flip angle = 9°, and slices = 176.
Voxel-based morphometry preprocessing
The processing and analysis of the structural images were performed using Statistical Parametric 30 This step involved multiplying each spatially normalized GM image by its relative volume before and after normalisation. The resulting GM images were smoothed with an 8-mm full width at half maximum [FWHM] isotropic Gaussian kernel.
Cortical thickness preprocessing

FreeSurfer
[https://surfer.nmr.mgh.harvard.edu/fswiki/FreeSurfer Wiki] was employed to measure cortical thickness and subcortical volume. Dale et al. 31 and Fischl et al. 32 have described a surfacebased analysis of cortical thickness. The images for magnetic field in homogeneities were corrected, registered to the Talairach-Tournoux atlas, 33 and skull-stripped. Parcellated surfaces were conducted on the two separate hemispheres using an automated process. 34 For each participant, this process was performed by homeomorphically mapping the pial surface to a spherical coordinate system, 35 in which the folding patterns were matched to an average map. The grey/white boundary representations were obtained after the surface model was constructed. The parcellation scheme 36 labelled the cortical sulci and the gyri, and the surface area and thickness values were subsequently calculated in the 66 regions. The cortical thickness was calculated as the average distance between the grey/white boundary and the pial surfaces within the regions. The global measures of cortical thickness were calculated as the averages of these regions.
Statistical analysis
At the second level of analysis, we initially adopted a two-sample t-test to estimate the differences in GM volume between the patients and the HCs. The statistical threshold was set at p < 0.05 (corrected for the family discovery rate [FDR]), and the cluster size exceeded 5. Total GM volumes, age, weight, and gender were deemed to be insignificant covariates. We performed statistical analyses by including anxiety and depression [with total GM volumes, gender, age, and weight] as covariates to evaluate the effects of anxiety and depression on VBM measures that differentiated the CD patients from the HCs. In addition to the above-mentioned covariates, anxiety and depression were combined and observed as an additional covariate to evaluate the psychosocial effects on the microstructural changes in all of the patients, because the HADS anxiety score [HADS-A] and the HADS depression score [HADS-D] were significantly correlated [r = 0.707, p < 0.001]. A similar analysis was also used to observe differences in cortical thickness between the patients and the HCs.
Based on the two-sample t-test results of the VBM between the patients and the HCs, regions of interest [ROIs] were selected from the sets of voxels within 6-mm spheres with the centres at the peaks of the activation clusters. A Pearson's correlation analysis was applied to examine the relationship between the mean GM volume in each ROI and the clinical variables [duration of disease] for the CD patients with total GM volumes, gender, age, weight, anxiety, and depression as covariates. The significance level was set at p < 0.05 with a Bonferroni correction. A similar analysis was also conducted to observe the relationship between the mean cortical thickness of the ROIs and the clinical variables from the two-sample t-test results for each group.
All of the imaging results were transformed into the MNI stereotactic space and overlaid on MRIcroN [http://www.sph.s.c.edu/ comd/rorden/mricro.html] for presentation purposes. 
The values are presented as mean values [standard deviations]. CD, Crohn's disease; CDAI, CD Activity Index; CDEIS, CD Endoscopic Index of Severity; CRP, C-reactive protein; ESR, eosinophil sedimentation rate; HADS-A or -D, Hospital Anxiety and Depression Scores; HCs, healthy controls; IBDQ, Inflammatory Bowel Disease Questionnaire; PLT, platelet levels.
All
The data are presented as the mean ± standard deviation.
Results
Clinical variables
The clinical and demographic characteristics of all of the subjects are shown in Table 1 None of the patients were smokers, and four of the patients had been treated with an anti-TNF-α agent [infliximab] .
Increased GM volume in CD
The results of statistical analysis, in which total GM volumes, gender, age, and weight were employed as covariates, showed that the GM volumes in the periaqueductal grey [PAG], bilateral putamen, left pallidum, HIPP, thalamus, precuneus, posterior parietal cortex [PPC], right amygdala, and cerebellum in the CD patients were significantly increased [p < 0.05, corrected].
The results of repeated statistical analysis, in which anxiety and depression were employed as covariates [with total GM volumes, gender, age, and weight], showed that the differences in GM volume in the amygdala and cerebellum disappeared, but differences in other brain regions were detected; however, the difference of the GM volume clusters in these brain regions decreased [ Table 2 , Figure 1A ].
Decreased GM volume in CD
The results of the statistical analysis, in which total GM volumes, gender, age, and weight were employed as covariates, showed that compared with the HCs, there were significant decreases in GM volumes in the bilateral anterior cingulate cortex [ACC], supplementary motor area [SMA], insula, postcentral gyrus, precentral gyrus, When anxiety and depression were employed as covariates [with total GM volumes, gender, age, and weight], repeated statistical analyses showed no significant differences in GM volume in the right SMA, precentral gyrus, superior frontal cortex, middle frontal cortex, left middle OFC, orinferior frontal cortex. Differences in other brain regions were identified; however, the difference decreased in the GM volume clusters in the brain regions [ Table 2 , Figure 1B] .
Cortical thickness
When total GM volumes, gender, age, and weight were employed as covariates, statistical analyses showed that there were significant The repeated correlation analysis, in which anxiety and depression were employed as covariates [with total GM volumes, gender, age, and weight], showed that the differences in cortical thickness in the left paraHIPP disappeared, and the intensity of the differences and/or the range of differences diminished in the right superior frontal cortex, left insula, rACC, postcentral gyrus, and right precentral gyrus. The differences in the other brain regions were not significant [ Table 3 , Figure 2A ]. [C] The decreased GM volumes in the dmPFC, insula, and ACC showed a significant negative correlation with CD duration. ACC, anterior cingulate cortex; Amyg, amygdala; dlPFC, dorsolateral prefrontal cortex; dmPFC, dorsomedial prefrontal cortex; HIPP, hippocampal cortex; MTC, middle temporal cortex; OFC, orbitofrontal cortex; PAG, periaqueductal grey; PCUN, precuneus; PPC, posterior parietal cortex; PREC, precentral gyrus; ROI, region of interest; S1, primary somatosensory cortex; SMA, supplementary motor area; TGMV, total GM volumes.
Correlation between GM structures and CD duration
We found significant negative correlations between the disease duration and the GM volumes of the right ACC, dmPFC, and left insula [ Figure 1C ]. The disease duration was also negatively correlated with the cortical thickness of the left insula and OFC [ Figure 2B ].
Discussion
In this study, we tested three hypotheses on the changes in brain GM structures in CD patients. First, we hypothesised that CD patients display altered GM structures including altered GM volume and cortical thickness. We found that brain regions with decreased GM volumes in CD patients were primarily localised in the cerebral cortex, whereas brain regions with increased GM volumes were primarily localised in the subcortical regions, cerebellum, and brain stem. Agostini et al. 11 showed decreased GM volumes in some regions of the dlPFC and anterior MCC in CD patients. Zikou AK et al. 13 found decreased GM volumes in the fusiform and in the bilateral inferior temporal gyrus; the right precentral gyrus, SMA, and middle frontal gyrus; and the left superior parietal gyrus in IBD patients. Based on the expanded sample sizes, our study also revealed a greater number of brain regions with altered GM volumes in CD patients. In particular, some brain regions with increased GM volumes were found. Agostini et al. 37 also showed that the amygdala, HIPP, insula, putamen, and cerebellum in CD patients exhibited significantly abnormal blood oxygen levels during stress-evoking tasks, which suggests that these patients have a reduced ability to self-adjust during stress. The present study confirmed that there were altered GM structures in these brain regions.
We represent the first evidence on changes in cortical thickness in CD patients. The decreased cortical thicknesses in the insula, ACC, PCC, paraHIPP, and some regions of the frontal cortex, temporal cortex, and parietal cortex in CD patients were different from the altered cortical thicknesses in UC patients shown by Hong JY et al. 19 . In addition, the identified reductions in both cortical thickness and GM volumes in multiple cortical and subcortical regions were consistent in CD patients by using VBM and cortical thickness analytical techniques.
Second, we hypothesised that psychological distress in CD patients, including anxiety and depression, may be correlated with brain GM structural changes. We found that when anxiety and depression factors were controlled, the difference in GM structures in the brain regions involved in the regulation of emotion and visceral sensation disappeared or the intensity of the difference decreased, which suggests the influence of psychological distress, such as anxiety and depression, on the GM structures of the brain in CD patients. Therefore, psychological distress may partially explain the anatomical differences between CD patients and HCs. The HADS scores of the CD patients were significantly higher than those of the HCs, and the CD patients exhibited different degrees of anxiety and depression, which was consistent with the results of previous studies. 16, 17 These results support a relationship between psychological distress and brain structural plasticity in CD.
Third, we hypothesised that changes in brain GM in CD patients are correlated with disease duration. The results showed that the GM volumes of the right ACC, dmPFC, and left insula and the cortical thickness of the left insula and OFC had significant negative correlations with disease duration. It suggests that the brain morphological changes might be at least in part secondary to the chronic intestinal disorder in CD.
Multiple brain regions participated in the processing of abnormal signals in the CNS of the CD patients. These brain regions are key components of the pain, emotion, attention, and homeostatic systems. Their impaired capacity can impede the normal triggering of analgesic responses, the ability to maintain positive emotions, and the homeostatic responses to noxious stimuli. We detected significant changes in the GM structures in the ACC, insula, thalamus, amygdala, SMA, PPC, prefrontal cortex [PFC], PAG, S1, and OFC. These cortical and subcortical regions are important components of the visceral sensory neuromatrix 38 and/or the pain neuromatrix. 39, 40 In addition, brain regions such as the insula, thalamus, and ACC are important components of the homeostatic afferent network 41, 42 and the central autonomic network. 43 The abnormality of these two networks in the brains of CD patients suggests a dysfunction of the autonomic nervous system and the hypothalamic-pituitary-adrenal axis [HPA axis] and an imbalance of the internal environment homeostasis. Previous studies have also demonstrated an uncoupling of the sympathetic nervous system and the HPA axis in CD patients, 44, 45 which suggests that the CD lesions are not limited to the gastrointestinal tract and that CD is a systemic disorder that involves an imbalanced homeostasis of the internal environment. In addition, the increased GM volumes in the putamen, thalamus, PAG, amygdale, and HIPP may be related to psychological distress in CD patients, as these regions are known to play a role in affective disorders. 46 The increased GM volumes in the HIPP may be related to the maladjustment of neural immune regulation in CD, as the HIPP regulates immune responses through HPA axis and neurohumoral pathways. 47 Abnormal GM structural changes in the brains of CD patients may be associated with many factors, such as pain, inflammation, emotion, and immunity. Intestinal inflammation/noxious stimulus signals can The decreased cortical thicknesses in the insula and the OFC showed a significant negative correlation with CD duration. CMF, caudal middle frontal cortex; IPC, inferior parietal cortex; OFC, orbitofrontal cortex; paraHIPP, parahippocampal cortex; PCC, posterior cingulate cortex; PREC, precentral gyrus; PTRI, pars triangularis; rACC, rostral anterior cingulate cortex; ROI, region of interest; S1, primary somatosensory cortex; SFC, superior frontal cortex; TC, temporal cortex; TGMV, total GM volumes.
be transmitted to the brain through vagal afferent fibres and gastrointestinal afferent sensory fibres of the spinal nerves, which are sequentially coded and interpreted at all levels and transmitted to the cortical and subcortical regions. Intestinal inflammatory signals can induce the apoptosis of astrocytes and oligodendrocytes, 48, 49 and activate microglial cells, macrophages, and endothelial cells in the brain to alter CNS excitability. 43, 50, 51 Studies have indicated that with systemic inflammatory stimuli during acute inflammation, the increased production of proinflammatory cytokines and chemokines in the brain and microglial cells serves an important role in communication between the brain and the systemic immune system. 52, 53 For example, increased TNF-α levels in the hippocampus and increased CNS excitability were detected in 2,4,6-trinitrobenzene sulfonic acid [TNBS]-induced intestinal inflammation rats. 51 Cytokines can be locally synthesised in the brain, and peripheral proinflammatory factors can also reach the brain through active transport and circumventricular organs. 43, 54 The present study contains several limitations. First, this is a cross-sectional study; the results of this study therefore cannot confirm the causality between the GM structural changes in CD patients and the onset of the disease. Second, given the high frequency of pain/IBS-like symptoms in IBD patients, 16, 55 it would be more valuable and informative to investigate the relationship between pain/IBS-like symptoms and brain structural changes. Third, multi-dimensional psychological evaluation of stress, 12 coping strategies, 56 and psychological adjustment [either positive or negative] 44 are also very important in IBD patients; this should be addressed in future studies.
In conclusion, this study provides further information regarding brain structural changes in CD patients. We detected significant changes in GM structures in multiple brain regions that are involved in pain, emotion, and homeostasis; these changes can be partially explained by the higher levels of anxiety and depression in these patients. Specific profiles of GM structural changes in the CD patients were correlated with disease duration.
